IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (CYTH)

CUSIP: 23254X201

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Class A common stock, $0.001 par value
Shares outstanding
162,474,849
Total 13F shares
457,420
Share change
+127,693
Total reported value
$1,705,000
Price per share
$3.73
Number of holders
12
Value change
+$475,888
Number of buys
6
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 23254X201?
CUSIP 23254X201 identifies CYTH - IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (CYTH) as of Q4 2021

As of 31 Dec 2021, IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (CYTH) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 457,420 shares. The largest 10 holders included VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Virtu Financial LLC, BlackRock Inc., UBS Group AG, TWO SIGMA ADVISERS, LP, ADVISOR GROUP HOLDINGS, INC., and MORGAN STANLEY. This page lists 12 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.